顔面紅斑治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Facial Erythema Drugs Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU0730）

◆商品コード：MMG23JU0730
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：70
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥481,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥625,300	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥721,500	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Facial Erythema Drugs Market 調査レポートは次の情報を含め、グローバルにおけるの顔面紅斑治療薬市場規模と予測を収録しています。・世界の顔面紅斑治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の顔面紅斑治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の顔面紅斑治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「Rx」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

顔面紅斑治療薬のグローバル主要企業は、Novartis、 Pfizer、 Sanofi-Aventis、 Merck、 Enzon Pharmaceuticals、 Bayer、 Astellas Pharma、 GSK、 Abbottなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、顔面紅斑治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の顔面紅斑治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の顔面紅斑治療薬市場：タイプ別市場シェア、2022年
・Rx、OTC

世界の顔面紅斑治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の顔面紅斑治療薬市場：用途別市場シェア、2022年
・病院、診療所、その他

世界の顔面紅斑治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の顔面紅斑治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における顔面紅斑治療薬のグローバル売上、2018年-2023年
・主要企業における顔面紅斑治療薬のグローバル売上シェア、2022年
・主要企業における顔面紅斑治療薬のグローバル販売量、2018年-2023年
・主要企業における顔面紅斑治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Novartis、 Pfizer、 Sanofi-Aventis、 Merck、 Enzon Pharmaceuticals、 Bayer、 Astellas Pharma、 GSK、 Abbott

*************************************************************

・調査・分析レポートの概要
顔面紅斑治療薬市場の定義
市場セグメント
世界の顔面紅斑治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の顔面紅斑治療薬市場規模
世界の顔面紅斑治療薬市場規模：2022年 VS 2029年
世界の顔面紅斑治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの顔面紅斑治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の顔面紅斑治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：Rx、OTC
顔面紅斑治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
顔面紅斑治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別顔面紅斑治療薬市場規模 2022年と2029年
地域別顔面紅斑治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Novartis、 Pfizer、 Sanofi-Aventis、 Merck、 Enzon Pharmaceuticals、 Bayer、 Astellas Pharma、 GSK、 Abbott
...

Drugs for Facial Erythema
This report aims to provide a comprehensive presentation of the global market for Facial Erythema Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Facial Erythema Drugs. This report contains market size and forecasts of Facial Erythema Drugs in global, including the following market information:
Global Facial Erythema Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Facial Erythema Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Facial Erythema Drugs companies in 2022 (%)
The global Facial Erythema Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Rx Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Facial Erythema Drugs include Novartis, Pfizer, Sanofi-Aventis, Merck, Enzon Pharmaceuticals, Bayer, Astellas Pharma, GSK and Abbott, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Facial Erythema Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Facial Erythema Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Facial Erythema Drugs Market Segment Percentages, by Type, 2022 (%)
Rx
OTC
Global Facial Erythema Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Facial Erythema Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Other
Global Facial Erythema Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Facial Erythema Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Facial Erythema Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Facial Erythema Drugs revenues share in global market, 2022 (%)
Key companies Facial Erythema Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Facial Erythema Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Pfizer
Sanofi-Aventis
Merck
Enzon Pharmaceuticals
Bayer
Astellas Pharma
GSK
Abbott
Outline of Major Chapters:
Chapter 1: Introduces the definition of Facial Erythema Drugs, market overview.
Chapter 2: Global Facial Erythema Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Facial Erythema Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Facial Erythema Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Facial Erythema Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Facial Erythema Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Facial Erythema Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Facial Erythema Drugs Overall Market Size
2.1 Global Facial Erythema Drugs Market Size: 2022 VS 2029
2.2 Global Facial Erythema Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Facial Erythema Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Facial Erythema Drugs Players in Global Market
3.2 Top Global Facial Erythema Drugs Companies Ranked by Revenue
3.3 Global Facial Erythema Drugs Revenue by Companies
3.4 Global Facial Erythema Drugs Sales by Companies
3.5 Global Facial Erythema Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Facial Erythema Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Facial Erythema Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Facial Erythema Drugs Players in Global Market
3.8.1 List of Global Tier 1 Facial Erythema Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Facial Erythema Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Facial Erythema Drugs Market Size Markets, 2022 & 2029
4.1.2 Rx
4.1.3 OTC
4.2 By Type – Global Facial Erythema Drugs Revenue & Forecasts
4.2.1 By Type – Global Facial Erythema Drugs Revenue, 2018-2023
4.2.2 By Type – Global Facial Erythema Drugs Revenue, 2024-2029
4.2.3 By Type – Global Facial Erythema Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Facial Erythema Drugs Sales & Forecasts
4.3.1 By Type – Global Facial Erythema Drugs Sales, 2018-2023
4.3.2 By Type – Global Facial Erythema Drugs Sales, 2024-2029
4.3.3 By Type – Global Facial Erythema Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Facial Erythema Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Facial Erythema Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Facial Erythema Drugs Revenue & Forecasts
5.2.1 By Application – Global Facial Erythema Drugs Revenue, 2018-2023
5.2.2 By Application – Global Facial Erythema Drugs Revenue, 2024-2029
5.2.3 By Application – Global Facial Erythema Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Facial Erythema Drugs Sales & Forecasts
5.3.1 By Application – Global Facial Erythema Drugs Sales, 2018-2023
5.3.2 By Application – Global Facial Erythema Drugs Sales, 2024-2029
5.3.3 By Application – Global Facial Erythema Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Facial Erythema Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Facial Erythema Drugs Market Size, 2022 & 2029
6.2 By Region – Global Facial Erythema Drugs Revenue & Forecasts
6.2.1 By Region – Global Facial Erythema Drugs Revenue, 2018-2023
6.2.2 By Region – Global Facial Erythema Drugs Revenue, 2024-2029
6.2.3 By Region – Global Facial Erythema Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Facial Erythema Drugs Sales & Forecasts
6.3.1 By Region – Global Facial Erythema Drugs Sales, 2018-2023
6.3.2 By Region – Global Facial Erythema Drugs Sales, 2024-2029
6.3.3 By Region – Global Facial Erythema Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Facial Erythema Drugs Revenue, 2018-2029
6.4.2 By Country – North America Facial Erythema Drugs Sales, 2018-2029
6.4.3 US Facial Erythema Drugs Market Size, 2018-2029
6.4.4 Canada Facial Erythema Drugs Market Size, 2018-2029
6.4.5 Mexico Facial Erythema Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Facial Erythema Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Facial Erythema Drugs Sales, 2018-2029
6.5.3 Germany Facial Erythema Drugs Market Size, 2018-2029
6.5.4 France Facial Erythema Drugs Market Size, 2018-2029
6.5.5 U.K. Facial Erythema Drugs Market Size, 2018-2029
6.5.6 Italy Facial Erythema Drugs Market Size, 2018-2029
6.5.7 Russia Facial Erythema Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Facial Erythema Drugs Market Size, 2018-2029
6.5.9 Benelux Facial Erythema Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Facial Erythema Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Facial Erythema Drugs Sales, 2018-2029
6.6.3 China Facial Erythema Drugs Market Size, 2018-2029
6.6.4 Japan Facial Erythema Drugs Market Size, 2018-2029
6.6.5 South Korea Facial Erythema Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Facial Erythema Drugs Market Size, 2018-2029
6.6.7 India Facial Erythema Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Facial Erythema Drugs Revenue, 2018-2029
6.7.2 By Country – South America Facial Erythema Drugs Sales, 2018-2029
6.7.3 Brazil Facial Erythema Drugs Market Size, 2018-2029
6.7.4 Argentina Facial Erythema Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Facial Erythema Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Facial Erythema Drugs Sales, 2018-2029
6.8.3 Turkey Facial Erythema Drugs Market Size, 2018-2029
6.8.4 Israel Facial Erythema Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Facial Erythema Drugs Market Size, 2018-2029
6.8.6 UAE Facial Erythema Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Facial Erythema Drugs Major Product Offerings
7.1.4 Novartis Facial Erythema Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Facial Erythema Drugs Major Product Offerings
7.2.4 Pfizer Facial Erythema Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Sanofi-Aventis
7.3.1 Sanofi-Aventis Company Summary
7.3.2 Sanofi-Aventis Business Overview
7.3.3 Sanofi-Aventis Facial Erythema Drugs Major Product Offerings
7.3.4 Sanofi-Aventis Facial Erythema Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi-Aventis Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Facial Erythema Drugs Major Product Offerings
7.4.4 Merck Facial Erythema Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 Enzon Pharmaceuticals
7.5.1 Enzon Pharmaceuticals Company Summary
7.5.2 Enzon Pharmaceuticals Business Overview
7.5.3 Enzon Pharmaceuticals Facial Erythema Drugs Major Product Offerings
7.5.4 Enzon Pharmaceuticals Facial Erythema Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Enzon Pharmaceuticals Key News & Latest Developments
7.6 Bayer
7.6.1 Bayer Company Summary
7.6.2 Bayer Business Overview
7.6.3 Bayer Facial Erythema Drugs Major Product Offerings
7.6.4 Bayer Facial Erythema Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Bayer Key News & Latest Developments
7.7 Astellas Pharma
7.7.1 Astellas Pharma Company Summary
7.7.2 Astellas Pharma Business Overview
7.7.3 Astellas Pharma Facial Erythema Drugs Major Product Offerings
7.7.4 Astellas Pharma Facial Erythema Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Astellas Pharma Key News & Latest Developments
7.8 GSK
7.8.1 GSK Company Summary
7.8.2 GSK Business Overview
7.8.3 GSK Facial Erythema Drugs Major Product Offerings
7.8.4 GSK Facial Erythema Drugs Sales and Revenue in Global (2018-2023)
7.8.5 GSK Key News & Latest Developments
7.9 Abbott
7.9.1 Abbott Company Summary
7.9.2 Abbott Business Overview
7.9.3 Abbott Facial Erythema Drugs Major Product Offerings
7.9.4 Abbott Facial Erythema Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Abbott Key News & Latest Developments
8 Global Facial Erythema Drugs Production Capacity, Analysis
8.1 Global Facial Erythema Drugs Production Capacity, 2018-2029
8.2 Facial Erythema Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Facial Erythema Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Facial Erythema Drugs Supply Chain Analysis
10.1 Facial Erythema Drugs Industry Value Chain
10.2 Facial Erythema Drugs Upstream Market
10.3 Facial Erythema Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Facial Erythema Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Facial Erythema Drugs in Global Market
Table 2. Top Facial Erythema Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Facial Erythema Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Facial Erythema Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Facial Erythema Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Facial Erythema Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Facial Erythema Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Facial Erythema Drugs Product Type
Table 9. List of Global Tier 1 Facial Erythema Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Facial Erythema Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Facial Erythema Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Facial Erythema Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Facial Erythema Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Facial Erythema Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Facial Erythema Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global Facial Erythema Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Facial Erythema Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Facial Erythema Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Facial Erythema Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Facial Erythema Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global Facial Erythema Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Facial Erythema Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Facial Erythema Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Facial Erythema Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Facial Erythema Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Facial Erythema Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Facial Erythema Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Facial Erythema Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Facial Erythema Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Facial Erythema Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Facial Erythema Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Facial Erythema Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Facial Erythema Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Facial Erythema Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Facial Erythema Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Facial Erythema Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Facial Erythema Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Facial Erythema Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Facial Erythema Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Facial Erythema Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Facial Erythema Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Facial Erythema Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Facial Erythema Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Facial Erythema Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Facial Erythema Drugs Sales, (K Units), 2024-2029
Table 46. Novartis Company Summary
Table 47. Novartis Facial Erythema Drugs Product Offerings
Table 48. Novartis Facial Erythema Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Facial Erythema Drugs Product Offerings
Table 52. Pfizer Facial Erythema Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. Sanofi-Aventis Company Summary
Table 55. Sanofi-Aventis Facial Erythema Drugs Product Offerings
Table 56. Sanofi-Aventis Facial Erythema Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Sanofi-Aventis Key News & Latest Developments
Table 58. Merck Company Summary
Table 59. Merck Facial Erythema Drugs Product Offerings
Table 60. Merck Facial Erythema Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Merck Key News & Latest Developments
Table 62. Enzon Pharmaceuticals Company Summary
Table 63. Enzon Pharmaceuticals Facial Erythema Drugs Product Offerings
Table 64. Enzon Pharmaceuticals Facial Erythema Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Enzon Pharmaceuticals Key News & Latest Developments
Table 66. Bayer Company Summary
Table 67. Bayer Facial Erythema Drugs Product Offerings
Table 68. Bayer Facial Erythema Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Bayer Key News & Latest Developments
Table 70. Astellas Pharma Company Summary
Table 71. Astellas Pharma Facial Erythema Drugs Product Offerings
Table 72. Astellas Pharma Facial Erythema Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Astellas Pharma Key News & Latest Developments
Table 74. GSK Company Summary
Table 75. GSK Facial Erythema Drugs Product Offerings
Table 76. GSK Facial Erythema Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. GSK Key News & Latest Developments
Table 78. Abbott Company Summary
Table 79. Abbott Facial Erythema Drugs Product Offerings
Table 80. Abbott Facial Erythema Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Abbott Key News & Latest Developments
Table 82. Facial Erythema Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 83. Global Facial Erythema Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Facial Erythema Drugs Production by Region, 2018-2023 (K Units)
Table 85. Global Facial Erythema Drugs Production by Region, 2024-2029 (K Units)
Table 86. Facial Erythema Drugs Market Opportunities & Trends in Global Market
Table 87. Facial Erythema Drugs Market Drivers in Global Market
Table 88. Facial Erythema Drugs Market Restraints in Global Market
Table 89. Facial Erythema Drugs Raw Materials
Table 90. Facial Erythema Drugs Raw Materials Suppliers in Global Market
Table 91. Typical Facial Erythema Drugs Downstream
Table 92. Facial Erythema Drugs Downstream Clients in Global Market
Table 93. Facial Erythema Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Facial Erythema Drugs Segment by Type in 2022
Figure 2. Facial Erythema Drugs Segment by Application in 2022
Figure 3. Global Facial Erythema Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Facial Erythema Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Facial Erythema Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Facial Erythema Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Facial Erythema Drugs Revenue in 2022
Figure 9. By Type - Global Facial Erythema Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Facial Erythema Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Facial Erythema Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Facial Erythema Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Facial Erythema Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Facial Erythema Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Facial Erythema Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Facial Erythema Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Facial Erythema Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Facial Erythema Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Facial Erythema Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Facial Erythema Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Facial Erythema Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Facial Erythema Drugs Sales Market Share, 2018-2029
Figure 23. US Facial Erythema Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Facial Erythema Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Facial Erythema Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Facial Erythema Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Facial Erythema Drugs Sales Market Share, 2018-2029
Figure 28. Germany Facial Erythema Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Facial Erythema Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Facial Erythema Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Facial Erythema Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Facial Erythema Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Facial Erythema Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Facial Erythema Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Facial Erythema Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Facial Erythema Drugs Sales Market Share, 2018-2029
Figure 37. China Facial Erythema Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Facial Erythema Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Facial Erythema Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Facial Erythema Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Facial Erythema Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Facial Erythema Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Facial Erythema Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Facial Erythema Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Facial Erythema Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Facial Erythema Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Facial Erythema Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Facial Erythema Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Facial Erythema Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Facial Erythema Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Facial Erythema Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Facial Erythema Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Facial Erythema Drugs by Region, 2022 VS 2029
Figure 54. Facial Erythema Drugs Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 顔面紅斑治療薬の世界市場見通し2023年-2029年(Facial Erythema Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

顔面紅斑治療薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp